Navigation Links
New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment

FAS20013, a tuberculosis drug, currently in the experimental phase has offered hope in the treatment of multiple drug resistant and latent infections as well. The mechanism of action of the new drug is different // than those used for conventional treatment.

The drug targets slow growing mycobacteria involved in the disease process and induces selective killing of the same. The other drugs target a broad spectrum of non-pathogenic microorganisms that enables development of drug resistance. Nearly all isolates have been shown to be susceptible to the compound and no resistance has been observed.

The compound is the first ever known to combat latent infection. Following infection, some patients go into a latent phase where no symptoms are seen. Such patients are not capable of infecting others, as they do not have an active infection. However, they can develop active infection at any time. Worldwide, more than 2 billion people have this latent form of the disease.

Furthermore, the drug action is precipitated in just 4 hours while Rifampicin or Isoniazid needs 12 to 14 hours to destroy the pathogen. The pharmaceutical company FASgen, Inc., is working towards marketing the novel drug for commercial use.

Overcoming multiple drug resistance in tuberculosis represents a significant challenge in the successful treatment of tuberculosis. It is associated with a fatality rate ranging from 20 to 80%. The presence of an uncontrollable active infection and failure to respond to any therapy are strong indications for isolation of the patient to prevent the emergence of drug resistant strains in the population. In worst cases, it may be even required to perform surgical resection of a part of the lung. The cost associated with such a treatment can be as high as $250,000.

The drug is currently being investigated in laboratory animals to estimate the beneficial and toxic effects. An application would soon be submitted to th e Food and Drug Administration (FDA) regarding proceeding with clinical trials of the investigational new drug (IND). If promising results are obtained, we could soon have an anti-tuberculous drug for treatment of MDR-TB.


'"/>




Related medicine news :

1. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. Health Minister Promises Strict Quality Control On Herbal Medicines
8. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
9. Nanotechnology Promises Huge Medical Benefits
10. Health Minister Promises New Benchmark for Wait Times
11. Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... Most of the time, ... system. However, changes in the color, smell, or consistency could be signs of ... and result in a low self-esteem for many women. Although Over-the-Counter (OTC) medications ...
(Date:11/16/2018)... ... ... AP was selected in the Health Care 2 ($10-$30M) Category and will ... the Hyatt Regency Downtown Dallas along with other companies who have illustrated exceptional qualities ... the Annual Excellence in Construction National Level Competition through Associated Builders and Contractors, Inc ...
(Date:11/16/2018)... , ... November 16, 2018 , ... CapRock Health, the ... of its first urgent care facility in the Century Square Development in College Station, ... access point for acute medical care to the Bryan and College Station area,” said ...
(Date:11/16/2018)... ... , ... Author and thought leader in health and patient-centered ... Medicine (GreenLeaf Press, 2018) was recently awarded a gold medal from Readers' Favorite ... patient stories with a historical overview that reveals interesting and untold details of ...
(Date:11/16/2018)... ... 16, 2018 , ... It may surprise many people to learn that 25 ... provide care and support that reflect the important contributions made by these men and ... a pioneering campaign developed by National Hospice and Palliative Care Organization (NHPCO) in collaboration ...
Breaking Medicine News(10 mins):
(Date:11/17/2018)... ... ... The International Society of Hair Restoration (ISHRS) recently held the 26th ... The event, held in Hollywood, California from October 10th-14th, was chaired by Dr. Parsa ... founder of Parsa Mohebi Hair Restoration in Los Angeles, “my first step ...
(Date:11/16/2018)... PHOENIX (PRWEB) , ... November 16, 2018 , ... America’s ... aging parents at the same time. Most turn a blind eye to the Silver ... nearly 37 Million baby boomers will turn 65 over the next decade. Did you ...
(Date:11/16/2018)... ... November 16, 2018 , ... Through its ... support in study design, planning, sample collection, and analysis to team of researchers ... between maternal depressive symptoms, infant cognitive/behavioral development, and the gut microbiome. , ...
Breaking Medicine Technology: